Stockscreener 앱 받기
21.47
0.05%
0.010
시간 외 거래:
21.46
-0.010
-0.05%
Day One Biopharmaceuticals Inc 주식(DAWN)의 최신 뉴스
[SC 14D9/A] Day One Biopharmaceuticals, Inc. Amended Tender Offer Recommendation - Stock Titan
[SC TO-T/A] Day One Biopharmaceuticals, Inc. Amended Third-Party Tender Offer | DAWN SEC FilingForm SC TO-T/A - Stock Titan
Access Industries group tenders Day One (DAWN) 12.9M-share stake at $21.50 - Stock Titan
Day One Biopharmaceuticals stock reaches 52-week high of $21.48 By Investing.com - Investing.com Australia
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year HighHere's What Happened - MarketBeat
Day One Biopharmaceuticals stock reaches 52-week high of $21.48 - Investing.com
Day One Biopharma to be acquired by Servier for $2.5B - MSN
Market Review: Is Day One Biopharmaceuticals Inc forming higher highs and higher lowsTrend Reversal & Trade Opportunity Analysis Reports - baoquankhu1.vn
DAWN Stock Price, Quote & Chart | DAY ONE BIOPHARMACEUTICALS I (NASDAQ:DAWN) - ChartMill
Earnings Recap: How does Day One Biopharmaceuticals Inc compare to its peers2026 Setups & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? - Finviz
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasda - ChartMill
(DAWN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Biotech M&A Spree Helps Lead SBIO to March Gains - ETF Database
Chart Watch: How does Day One Biopharmaceuticals Inc compare to its peers - baoquankhu1.vn
Servier (DAWN) wins FTC early HSR termination, clearing HSR hurdle for tender offer - Stock Titan
HSR waiting period ends for Day One Biopharma (NASDAQ: DAWN) — Offer stays subject to conditions - Stock Titan
Swing Trade: How is Day One Biopharmaceuticals Inc managing supply chain issues2026 Technicals & Weekly Market Pulse Alerts - baoquankhu1.vn
FMR LLC holds 23,639.69 shares in Day One Biopharmaceuticals (NASDAQ: DAWN) amendment - Stock Titan
JonesTrading Maintains Day One Biopharmaceuticals(DAWN.US) With Hold Rating, Maintains Target Price $21.5 - Moomoo
Aug Levels: Is Day One Biopharmaceuticals Inc a strong growth stock2026 Action & Low Volatility Stock Recommendations - baoquankhu1.vn
Is Day One Biopharmaceuticals Inc a turnaround story2026 Key Highlights & Trade Opportunity Analysis - baoquankhu1.vn
Day One Biopharmaceuticals price target raised to $36 from $32 at JPMorgan - tipranks.com
SG Americas Securities LLC Buys 323,747 Shares of Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Day One Biopharmaceuticals (NASDAQ:DAWN) Hits New 12-Month HighShould You Buy? - MarketBeat
Baker McKenzie Advises Servier on the Acquisition of Day One Biopharmaceuticals for Approximately USD 2.5 Billion - Legal Desire Media and Insights
DAWN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Hennion & Walsh Asset Management Inc. Buys 218,383 Shares of Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Breakout Move: Is Day One Biopharmaceuticals Inc a turnaround storyWeekly Stock Summary & Community Verified Trade Signals - baoquankhu1.vn
Earnings Miss: Is Day One Biopharmaceuticals Inc a top pick in the sectorTake Profit & Safe Capital Growth Stock Tips - baoquankhu1.vn
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Short Interest Down 20.3% in March - MarketBeat
Day One Biopharmaceuticals (DAWN) price target decreased by 10.27% to 21.16 - MSN
(DAWN) Risk Channels and Responsive Allocation - Stock Traders Daily
Are SEM, DAWN, VRE Obtaining Fair Deals for their Shareholders? - The Malaysian Reserve
Day One Biopharmaceuticals Executives Sell Shares Amid Legal Firm's Scrutiny of $21.50 Offer - Bitget
Vanguard amends holdings for Day One Biopharmaceuticals (NASDAQ: DAWN), reports 0 shares - Stock Titan
Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc.DAWN - The AI Journal
Servier adds exhibit to Day One Biopharma tender offer (DAWN) - Stock Titan
Servier offers $21.50 per share for Day One (NASDAQ: DAWN) in agreed deal - Stock Titan
Servier (DAWN) offers $21.50 in cash to buy Day One Biopharma shares - Stock Titan
GLAZER CAPITAL, LLC Acquires Significant Stake in Day One Biopha - GuruFocus
Biggest stock movers Friday: MRVL, GAP, DAWN, GPRO, and more - MSN
SunOpta Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SunOpta Inc.STKL - Business Wire
Servier (DAWN) plans tender offer under March 6, 2026 merger agreement - Stock Titan
Aug Breakouts: Will Day One Biopharmaceuticals Inc stock go up in YEAR2026 Intraday Action & High Conviction Buy Zone Alerts - baoquankhu1.vn
Day One Biopharmaceuticals stock hits 52-week high at $21.44 By Investing.com - Investing.com Australia
Day One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 1-Year HighShould You Buy? - MarketBeat
Day One Biopharmaceuticals stock hits 52-week high at $21.44 - Investing.com
Glazer Capital (NASDAQ: DAWN) reports 5.6M-share, 5.44% stake - Stock Titan
Take Profit: Is Day One Biopharmaceuticals Inc a strong growth stockStock Surge & AI Driven Stock Reports - baoquankhu1.vn
Day One Biopharmaceuticals reiterates $225M–$250M OJEMDA revenue target as pipeline expands with Emi-Le integration - MSN
2.69%
0.25%
자본화:
|
볼륨(24시간):